280 related articles for article (PubMed ID: 31100828)
21. The emerging role of immune checkpoint based approaches in AML and MDS.
Boddu P; Kantarjian H; Garcia-Manero G; Allison J; Sharma P; Daver N
Leuk Lymphoma; 2018 Apr; 59(4):790-802. PubMed ID: 28679300
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell vaccination in acute myeloid leukemia.
Anguille S; Willemen Y; Lion E; Smits EL; Berneman ZN
Cytotherapy; 2012 Jul; 14(6):647-56. PubMed ID: 22686130
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
24. Role of interleukins in acute myeloid leukemia.
Wang Y; Tang X; Zhu Y; Yang XX; Liu B
Leuk Lymphoma; 2023; 64(8):1400-1413. PubMed ID: 37259867
[TBL] [Abstract][Full Text] [Related]
25. The role of lipids mediators in inflammation and resolution.
de Paula Rogerio A; Sorgi CA; Sadikot R; Carlo T
Biomed Res Int; 2015; 2015():605959. PubMed ID: 25879029
[No Abstract] [Full Text] [Related]
26. Platelets: Angels and Demons Dancing on the Immune Stage. Nutrition Conducts the Orchestra.
Magrone T; Magrone M; Russo MA; Jirillo E
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1196-1218. PubMed ID: 32875988
[TBL] [Abstract][Full Text] [Related]
27. Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology".
García-Guerrero E; Sánchez-Abarca LI; Domingo E; Ramos TL; Bejarano-García JA; Gonzalez-Campos JA; Caballero-Velázquez T; Pérez-Simón JA
Front Immunol; 2018; 9():1971. PubMed ID: 30233577
[TBL] [Abstract][Full Text] [Related]
28. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.
Fernandez C; Santos-Silva MC; López A; Matarraz S; Jara-Acevedo M; Ciudad J; Gutierrez ML; Sánchez ML; Salvador-Osuna C; Berruezo MJ; Díaz-Arias JÁ; Palomo-Hernández AM; Colado E; González N; Gallardo D; Asensio A; García-Sánchez R; Saldaña R; Cerveró C; Carboné-Bañeres A; Gutierrez O; Orfao A
Leukemia; 2013 Nov; 27(11):2149-56. PubMed ID: 23579575
[TBL] [Abstract][Full Text] [Related]
29. Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.
Adili R; Hawley M; Holinstat M
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():10-18. PubMed ID: 30266534
[TBL] [Abstract][Full Text] [Related]
30. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
31. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
32. Fatty acids as modulators of the immune response.
Fritsche K
Annu Rev Nutr; 2006; 26():45-73. PubMed ID: 16848700
[TBL] [Abstract][Full Text] [Related]
33. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.
Kim K; Jung N; Lee K; Choi J; Kim S; Jun J; Kim E; Kim D
Clin Nutr; 2013 Oct; 32(5):855-62. PubMed ID: 23395256
[TBL] [Abstract][Full Text] [Related]
34. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
Peled A; Klein S; Beider K; Burger JA; Abraham M
Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
[TBL] [Abstract][Full Text] [Related]
35. n-3 polyunsaturated fatty acids and cancer.
Bougnoux P
Curr Opin Clin Nutr Metab Care; 1999 Mar; 2(2):121-6. PubMed ID: 10453342
[TBL] [Abstract][Full Text] [Related]
36. Intravenous fish oil in critically ill and surgical patients - Historical remarks and critical appraisal.
Kreymann KG; Heyland DK; de Heer G; Elke G
Clin Nutr; 2018 Jun; 37(3):1075-1081. PubMed ID: 28747247
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy.
Acheampong DO; Adokoh CK; Asante DB; Asiamah EA; Barnie PA; Bonsu DOM; Kyei F
Biomed Pharmacother; 2018 Jan; 97():225-232. PubMed ID: 29091870
[TBL] [Abstract][Full Text] [Related]
38. The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators.
Binder S; Luciano M; Horejs-Hoeck J
Cytokine Growth Factor Rev; 2018 Oct; 43():8-15. PubMed ID: 30181021
[TBL] [Abstract][Full Text] [Related]
39. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
40. [The modulation of the function of the immunocompetent system and of nonspecific body resistance in rats with different ratios of essential fatty acids in the diet].
Volgarev MN; Levachev MM; Trushchina EN; Sergeeva KV; Kulakova SN; Aseeva LE; Mustafina OK; Tokareva TV
Biull Eksp Biol Med; 1993 Dec; 116(12):607-9. PubMed ID: 8123817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
